# Appco Pharma, LLC – FDA Inspection, Apr 15, 2019

Source: https://www.keypedia.com/records/fda_inspections/appco-pharma-llc/debac5be-64ab-45ab-b764-45c58793eee2
Source feed: FDA_Inspections

> FDA inspection 1086303 of Appco Pharma, LLC, April 15, 2019. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 314. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1086303
- Company Name: Appco Pharma, LLC
- Inspection Date: 2019-04-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Postmarket Surv. and Epidemiology
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1042697 - 2018-02-15
- FDA Inspection 979709 - 2016-06-27
- FDA Inspection 892288 - 2014-08-21
- FDA Inspection 862390 - 2014-01-16
- [FDA Inspection 759813 - 2011-12-22](https://www.keypedia.com/records/fda_inspections/appco-pharma-llc/6e2b7b65-1d7d-4055-a708-fea05cee1fad)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/nina-yang/8d080437-2e05-4b75-8c53-b818d761cf1f)

Company: https://www.keypedia.com/companies/appco-pharma-llc/63262db1-9074-411f-915f-f0b3e49884b8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c